Update of New Daily Persistent Headache

Curr Pain Headache Rep. 2022 Jan;26(1):79-84. doi: 10.1007/s11916-022-01005-1. Epub 2022 Jan 25.


Purpose of review: The diagnostic criteria of new daily persistent headache (NDPH) have been revised since 2013. The current review focused on the progress of NDPH research over the last few years.

Recent findings: Various new triggers and different NDPH mimics have been reported. The association with both cephalic and extracephalic pathologies suggests that NDPH is rather a syndrome with more than one disease mechanism. Recent clinical studies confirmed that migrainous headache remained the most prominent phenotype of NDPH, echoing the change of the diagnostic criteria in 2013. Diagnostic workup, including imaging studies, was unremarkable, except serving to exclude secondary etiologies. Studies on treatment options have yet shown promising targets, and randomized clinical trials are still lacking. Multiple mechanisms, both cranial and systemic, may be involved synergically in the generation of NDPH-like headaches. The search for effective treatment options should base on better understanding of disease mechanisms.

Keywords: COVID-19; Infection; Migrainous; NDPH; Post-infection; RCVS.

Publication types

  • Review

MeSH terms

  • Headache / diagnosis
  • Headache / therapy
  • Headache Disorders* / diagnosis
  • Headache Disorders* / therapy
  • Humans
  • Migraine Disorders*
  • Syndrome
  • Treatment Outcome